Keywords
How to Cite
Abstract
The purpose of this study was to determine the prognostic significance of dynamics of C-reactive protein concentration in blood plasma as a marker for the progression of squamous cell carcinoma of the oral cavity mucosa. From January 2014 to August 2014 there were under the observation 35 patients with squamous cell carcinoma of the oral cavity mucosa. All patients were divided into 2 groups: group 1 - primary patients who had been diagnosed with malignant lesions of the oral cavity mucosa for the first time (17 people); group 2 - patients with recurrent disease (18 people). All 17 patients of group 1 received induction polychemotherapy by PF scheme and 18 patients of group 2 - curative polychemotherapy by the following schemes: PF, DCF, TC. In all patients there was performed an assessment of the level of C-reactive protein in blood serum at the stage prior to drug treatment and before each subsequent cycle of chemotherapy. An assessment of the level of C-reactive protein before treatment showed that in 17 patients of group 1 its level was in the normal range. Patients of group 2 had an increased concentration of C-reactive protein in blood plasma. Analysis of obtained data allows concluding that the level of C-reactive protein may be effectively used as a prognostic marker in patients with this pathology.References
Andersson B.A., Lewin F., Lundgren J. et al. Plasma tumor necrosis factor-а and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma // J Cancer Res Clin Oncol. - 2014. - Vol. 140 (3). - P 515-519.
Chang P.Y., Kuo Y.B., Wu T.L. et al. Association and prognostic value of serum inflammation markers in patient with leukoplakia and oral cavity cancer // Clin Chem Lab Med. - 2013. - Vol. 51(6). - P. 1291-1300.
Choudhury B., Srivastava S., Choudhury H. et al. Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India // Tumou Biol. - 2014. - Vol. 35 (7). - P. 6739-6748.
Coussens L.M., Werb Z. Inflammation and cancer // Nature. - 2002. - Vol. 420. - P. 860-867.
Felekis D., Eleftheriadou A., Papadakos G. et al. Effect of perioperative immuno-enhaced enteral nutrition on inflammantory response, nutritional status, and outcomes in head and neck cancer patient undergoing major surgery // Nutr Cancer. - 2010. - Vol. 62 (8). - P 1105-1112.
Gallo O., Gori A.M., Attanasio M. et al. Interleukin-6 and acute-phase proteins in head and neck cancer // Eur Arch Otorhinolaryngol. - 1995. - Vol. 252 (3). - P. 159-162.
Kruzhe A., Luebbers H., Gratz K. C-reactive protein levels: a prognostic marker for patients with head and neck cancer? // Head Neck Oncol. - 2010. - Vol. 2. - P. 21.
Kulpa J., Stasik Z., Skolyszewski J. et al. Predictive value of SCC-Ag, CYFRA 21-1 and selected acute phase proteins in radiotherapy of pharyngeal andlaryngeal cancer // A preliminary report.
Machon C., Thezenas S., Dupuy A.M. et al. Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients // Support Care Cancer. - 2012. - Vol. 20 (12). - P 3129-3135.
Peter F., Wittekindt C., Finkensieper M. et al. Prognostic impact of pretherapeutic laboratory values in head and neck cancer patient // J Cancer Res Clin Oncol. - 2013. - Vol. 139 (1). - P. 171-178.
Tartour E., Deneux L., Mosseri V. et al. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study // Cancer. - 1997. - Vol. 79 (7). - P 1401-1408.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...